14-PUB: The Effect of Structured Intensive Lifestyle Intervention on Muscle Mass in Patients with Type 2 Diabetes Receiving GLP-1 Receptor Agonists

Glucagon-like-peptide-1 receptor agonists (GLP-1RAs) emerged as an important treatment option for type 2 diabetes (T2D) for their dual efficacy in improving glycemia and reducing body weight. However, they significantly reduce fat free mass (FFM), a surrogate for muscle mass, putting patients at a h...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73, p.1
Hauptverfasser:	Al-Badri, Marwa, Askar, Abd Almasih Barbar, Khater, Abdelrahman, Salah, Tareq, Dhaver, Shilton E, Al-Roomi, Fatimah, Mottalib, Adham, Hamdy, Osama
Format:	Artikel
Sprache:	eng
Schlagworte:	Agonists Blood glucose Body composition Body weight Complications Diabetes Diabetes mellitus (non-insulin dependent) Glucagon Nutrition therapy Patients Proteins Sarcopenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!